@FierceBiotech: In case you missed it last week: Looks like an exciting year from JPM13. Slideshow | Follow @FierceBiotech
@JohnCFierce: Activists cry havoc, let slip the dogs of war on AstraZeneca. News | Follow @JohnCFierce
@RyanMFierce: PatientsLikeMe tackles extremely rare genetic disease. Item | Follow @RyanMFierce
> As operations wind down for Roche's ($RHHBY) sprawling campus in Nutley, NJ, company officials and local economic development groups are focusing on opening a new chapter for the facilities. Report
> Shares of Neuralstem ($CUR) were buoyed this morning by the news that it won a regulatory green light for a Phase I study of its lead cell therapy candidate, NSI-566, in chronic spinal cord injury patients. Release
> New research indicates that a molecular switch could play a major role in tumor suppression. Release
Pharma News
@FiercePharma: Zytiga wins European approval for earlier use. FDA did the same in December. Could be big for Janssen/J&J. More | Follow @FiercePharma
@AlisonBFierce: Widespread flu outbreak gives vaccine manufacturers a shot in the arm. News | Follow @AlisonBFierce
> Generic Reglan user can sue Pfizer for damages. Article
> Brand-new AbbVie reveals second Synthroid recall. News
> India to hit Roche, BMS with compulsory licenses on 3 cancer drugs. Story
@FierceMedDev: Experts: Odds of device tax repeal close to zero. Item | Follow @FierceMedDev
@MarkHFierce: Covidien begins post-approval study for stroke treatment device. More | Follow @MarkHFierce
@DamianFierce: Last thing from JPM13: Talking Chinese outsourcing with Vertex, Merck, MedImmune and WuXi. Story | Follow @DamianFierce
> Zimmer shutters Austin plant, plots Twin Cities move. News
> J&J's other hip device lands it back in court. Story
Biotech IT News
> How 'open' will Big Pharma get to treat R&D ills? Item
> Computer game rewards players for shirking flu shots. Report
> Elsevier snaps up drug R&D software company. Article
> Illumina, Life Tech trumpet startup efforts in clinical genomics. News
CRO News
> Report: Indian drug-related trial deaths rose in 2012. Report
> goBalto inks deal with INC for trial software. Article
> Catalent breathes $20M into inhalant business. News
> GVK partners with Onconova on cancer drugs. Story
> Parexel chief named ACRO chairman. Item
And Finally… A new study finds that children who regularly indulge themselves with fast food suffer higher rates of asthma and eczema. Story